{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:49:37Z","timestamp":1792900177725,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00125-018-4579-1","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T08:29:48Z","timestamp":1519892988000},"page":"1435-1446","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents"],"prefix":"10.1007","volume":"61","author":[{"given":"Daniel F.","family":"Vatner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Goedeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao-Paulo G.","family":"Camporez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali R.","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Bhanot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan F.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Still","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn S.","family":"Gerhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald I.","family":"Shulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varman T.","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,1]]},"reference":[{"key":"4579_CR1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/ijo.2017.4","volume":"41","author":"DJ Cuthbertson","year":"2017","unstructured":"Cuthbertson DJ, Steele T, Wilding JP et al (2017) What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications? Int J Obes 41:853\u2013865","journal-title":"Int J Obes"},{"key":"4579_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng.3714","volume":"49","author":"LA Lotta","year":"2017","unstructured":"Lotta LA, Gulati P, Day FR et al (2017) Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance. Nat Genet 49:17\u201326","journal-title":"Nat Genet"},{"key":"4579_CR3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1172\/JCI10583","volume":"106","author":"GI Shulman","year":"2000","unstructured":"Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106:171\u2013176","journal-title":"J Clin Invest"},{"key":"4579_CR4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.cmet.2014.08.005","volume":"20","author":"RE Soccio","year":"2014","unstructured":"Soccio RE, Chen ER, Lazar MA (2014) Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. Cell Metab 20:573\u2013591","journal-title":"Cell Metab"},{"key":"4579_CR5","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2337\/diabetes.51.3.797","volume":"51","author":"AB Mayerson","year":"2002","unstructured":"Mayerson AB, Hundal RS, Dufour S et al (2002) The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes 51:797\u2013802","journal-title":"Diabetes"},{"key":"4579_CR6","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.2337\/diabetes.52.6.1311","volume":"52","author":"JK Kim","year":"2003","unstructured":"Kim JK, Fillmore JJ, Gavrilova O et al (2003) Differential effects of rosiglitazone on skeletal muscle and liver insulin resistance in A-ZIP\/F-1 fatless mice. Diabetes 52:1311\u20131318","journal-title":"Diabetes"},{"key":"4579_CR7","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1161\/CIRCULATIONAHA.116.024863","volume":"20","author":"LH Young","year":"2017","unstructured":"Young LH, Viscoli CM, Curtis JP et al (2017) Cardiac outcomes after ischemic stroke or TIA: effects of pioglitazone in patients with insulin resistance without diabetes. Circulation 20:1882\u20131893","journal-title":"Circulation"},{"key":"4579_CR8","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJMoa1506930","volume":"374","author":"WN Kernan","year":"2016","unstructured":"Kernan WN, Viscoli CM, Furie KL et al (2016) Pioglitazone after ischemic stroke or transient ischemic attack. N Engl J Med 374:1321\u20131331","journal-title":"N Engl J Med"},{"key":"4579_CR9","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMoa060326","volume":"355","author":"R Belfort","year":"2006","unstructured":"Belfort R, Harrison SA, Brown K et al (2006) A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med 355:2297\u20132307","journal-title":"N Engl J Med"},{"key":"4579_CR10","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/hep.23116","volume":"50","author":"A Gastaldelli","year":"2009","unstructured":"Gastaldelli A, Harrison SA, Belfort-Aguilar R et al (2009) Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology 50:1087\u20131093","journal-title":"Hepatology"},{"key":"4579_CR11","doi-asserted-by":"crossref","unstructured":"Cusi K, Orsak B, Bril F et al (2016) Long-term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: a randomized trial. Ann Intern Med 165: 305\u2013315","DOI":"10.7326\/M15-1774"},{"key":"4579_CR12","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1007\/s00204-016-1737-4","volume":"90","author":"CV Rizos","year":"2016","unstructured":"Rizos CV, Kei A, Elisaf MS (2016) The current role of thiazolidinediones in diabetes management. Arch Toxicol 90:1861\u20131881","journal-title":"Arch Toxicol"},{"key":"4579_CR13","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.bbalip.2014.03.013","volume":"1841","author":"S Kersten","year":"2014","unstructured":"Kersten S (2014) Physiological regulation of lipoprotein lipase. Biochim Biophys Acta 1841:919\u2013933","journal-title":"Biochim Biophys Acta"},{"key":"4579_CR14","doi-asserted-by":"publisher","first-page":"150272","DOI":"10.1098\/rsob.150272","volume":"6","author":"R Zhang","year":"2016","unstructured":"Zhang R (2016) The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking. Open Biol 6:150272","journal-title":"Open Biol"},{"key":"4579_CR15","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1056\/NEJMoa0907295","volume":"362","author":"KF Petersen","year":"2010","unstructured":"Petersen KF, Dufour S, Hariri A et al (2010) Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med 362:1082\u20131089","journal-title":"N Engl J Med"},{"key":"4579_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1471-2350-8-80","volume":"8","author":"RL Pollex","year":"2007","unstructured":"Pollex RL, Ban MR, Young TK et al (2007) Association between the -455T>C promoter polymorphism of the APOC3 gene and the metabolic syndrome in a multi-ethnic sample. BMC Med Genet 8:80","journal-title":"BMC Med Genet"},{"key":"4579_CR17","doi-asserted-by":"publisher","first-page":"19751","DOI":"10.1073\/pnas.1217552109","volume":"109","author":"F Quagliarini","year":"2012","unstructured":"Quagliarini F, Wang Y, Kozlitina J et al (2012) Atypical angiopoietin-like protein that regulates ANGPTL3. Proc Natl Acad Sci U S A 109:19751\u201319756","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4579_CR18","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.cell.2013.04.008","volume":"153","author":"P Yi","year":"2013","unstructured":"Yi P, Park JS, Melton DA (2013) Betatrophin: a hormone that controls pancreatic beta cell proliferation. Cell 153:747\u2013758","journal-title":"Cell"},{"key":"4579_CR19","doi-asserted-by":"publisher","first-page":"e0159276","DOI":"10.1371\/journal.pone.0159276","volume":"11","author":"AR Cox","year":"2016","unstructured":"Cox AR, Barrandon O, Cai EP et al (2016) Resolving discrepant findings on ANGPTL8 in beta-cell proliferation: a collaborative approach to resolving the betatrophin controversy. PLoS One 11:e0159276","journal-title":"PLoS One"},{"key":"4579_CR20","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1210\/jc.2016-2084","volume":"101","author":"J Gomez-Ambrosi","year":"2016","unstructured":"Gomez-Ambrosi J, Pascual-Corrales E, Catalan V et al (2016) Altered concentrations in dyslipidemia evidence a role for ANGPTL8\/betatrophin in lipid metabolism in humans. J Clin Endocrinol Metab 101:3803\u20133811","journal-title":"J Clin Endocrinol Metab"},{"key":"4579_CR21","doi-asserted-by":"publisher","first-page":"E334","DOI":"10.1152\/ajpendo.00084.2012","volume":"303","author":"G Ren","year":"2012","unstructured":"Ren G, Kim JY, Smas CM (2012) Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. Am J Phys Endocrinol Metab 303:E334\u2013E351","journal-title":"Am J Phys Endocrinol Metab"},{"key":"4579_CR22","doi-asserted-by":"crossref","unstructured":"Haller JF, Mintah IJ, Shihanian LM et al (2017) ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance. J Lipid Res 58:1166\u20131173","DOI":"10.1194\/jlr.M075689"},{"key":"4579_CR23","doi-asserted-by":"publisher","first-page":"E1299","DOI":"10.1210\/jc.2015-1254","volume":"100","author":"PA Nidhina Haridas","year":"2015","unstructured":"Nidhina Haridas PA, Soronen J, Sadevirta S et al (2015) Regulation of angiopoietin-like proteins (ANGPTLs) 3 and 8 by insulin. J Clin Endocrinol Metab 100:E1299\u2013E1307","journal-title":"J Clin Endocrinol Metab"},{"key":"4579_CR24","doi-asserted-by":"publisher","first-page":"16109","DOI":"10.1073\/pnas.1315292110","volume":"110","author":"Y Wang","year":"2013","unstructured":"Wang Y, Quagliarini F, Gusarova V et al (2013) Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc Natl Acad Sci U S A 110:16109\u201316114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4579_CR25","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1128\/MCB.21.14.4785-4806.2001","volume":"21","author":"JS Bogan","year":"2001","unstructured":"Bogan JS, McKee AE, Lodish HF (2001) Insulin-responsive compartments containing GLUT4 in 3T3-L1 and CHO cells: regulation by amino acid concentrations. Mol Cell Biol 21:4785\u20134806","journal-title":"Mol Cell Biol"},{"key":"4579_CR26","doi-asserted-by":"publisher","first-page":"50230","DOI":"10.1074\/jbc.M200958200","volume":"277","author":"C Yu","year":"2002","unstructured":"Yu C, Chen Y, Cline GW et al (2002) Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277:50230\u201350236","journal-title":"J Biol Chem"},{"key":"4579_CR27","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1172\/JCI30400","volume":"117","author":"VT Samuel","year":"2007","unstructured":"Samuel VT, Liu ZX, Wang A et al (2007) Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J Clin Invest 117:739\u2013745","journal-title":"J Clin Invest"},{"key":"4579_CR28","doi-asserted-by":"publisher","first-page":"E89","DOI":"10.1152\/ajpendo.00573.2012","volume":"305","author":"DF Vatner","year":"2013","unstructured":"Vatner DF, Weismann D, Beddow SA et al (2013) Thyroid hormone receptor-beta agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways. Am J Phys Endocrinol Metab 305:E89\u2013E100","journal-title":"Am J Phys Endocrinol Metab"},{"key":"4579_CR29","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1002\/hep.24571","volume":"54","author":"HY Lee","year":"2011","unstructured":"Lee HY, Birkenfeld AL, Jornayvaz FR et al (2011) Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance. Hepatology 54:1650\u20131660","journal-title":"Hepatology"},{"key":"4579_CR30","doi-asserted-by":"publisher","first-page":"16381","DOI":"10.1073\/pnas.1113359108","volume":"108","author":"N Kumashiro","year":"2011","unstructured":"Kumashiro N, Erion DM, Zhang D et al (2011) Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci U S A 108:16381\u201316385","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4579_CR31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1677\/joe.0.1620207","volume":"162","author":"X Qu","year":"1999","unstructured":"Qu X, Seale JP, Donnelly R (1999) Tissue and isoform-selective activation of protein kinase C in insulin-resistant obese Zucker rats - effects of feeding. J Endocrinol 162:207\u2013214","journal-title":"J Endocrinol"},{"key":"4579_CR32","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45","journal-title":"Nucleic Acids Res"},{"key":"4579_CR33","first-page":"63","volume":"233","author":"JJ Sando","year":"2003","unstructured":"Sando JJ, Beals JK (2003) Enzyme assays for protein kinase C activity. Methods Mol Biol 233:63\u201376","journal-title":"Methods Mol Biol"},{"key":"4579_CR34","first-page":"H1771","volume":"277","author":"P Ping","year":"1999","unstructured":"Ping P, Zhang J, Huang S et al (1999) PKC-dependent activation of p46\/p54 JNKs during ischemic preconditioning in conscious rabbits. Am J Phys 277:H1771\u2013H1785","journal-title":"Am J Phys"},{"key":"4579_CR35","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1007\/s11695-015-1707-6","volume":"25","author":"A Petrick","year":"2015","unstructured":"Petrick A, Benotti P, Wood GC et al (2015) Utility of ultrasound, transaminases, and visual inspection to assess nonalcoholic fatty liver disease in bariatric surgery patients. Obes Surg 25:2368\u20132375","journal-title":"Obes Surg"},{"key":"4579_CR36","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/ijo.2013.152","volume":"38","author":"GS Gerhard","year":"2014","unstructured":"Gerhard GS, Styer AM, Strodel WE et al (2014) Gene expression profiling in subcutaneous, visceral and epigastric adipose tissues of patients with extreme obesity. Int J Obes 38:371\u2013378","journal-title":"Int J Obes"},{"key":"4579_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1472-6947-12-45","volume":"12","author":"GC Wood","year":"2012","unstructured":"Wood GC, Chu X, Manney C et al (2012) An electronic health record-enabled obesity database. BMC Med Inform Decis Mak 12:45","journal-title":"BMC Med Inform Decis Mak"},{"key":"4579_CR38","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.cmet.2014.08.002","volume":"20","author":"SM Turpin","year":"2014","unstructured":"Turpin SM, Nicholls HT, Willmes DM et al (2014) Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. Cell Metab 20:678\u2013686","journal-title":"Cell Metab"},{"key":"4579_CR39","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.cmet.2014.09.015","volume":"20","author":"S Raichur","year":"2014","unstructured":"Raichur S, Wang ST, Chan PW et al (2014) CerS2 haploinsufficiency inhibits beta-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance. Cell Metab 20:687\u2013695","journal-title":"Cell Metab"},{"key":"4579_CR40","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1159\/000453174","volume":"40","author":"AU Blachnio-Zabielska","year":"2016","unstructured":"Blachnio-Zabielska AU, Chacinska M, Vendelbo MH, Zabielski P (2016) The crucial role of C18-Cer in fat-induced skeletal muscle insulin resistance. Cell Physiol Biochem 40:1207\u20131220","journal-title":"Cell Physiol Biochem"},{"key":"4579_CR41","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1172\/JCI86013","volume":"126","author":"MC Petersen","year":"2016","unstructured":"Petersen MC, Madiraju AK, Gassaway BM et al (2016) Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance. J Clin Invest 126:4361\u20134371","journal-title":"J Clin Invest"},{"key":"4579_CR42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1172\/JCI77812","volume":"126","author":"VT Samuel","year":"2016","unstructured":"Samuel VT, Shulman GI (2016) The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest 126:12\u201322","journal-title":"J Clin Invest"},{"key":"4579_CR43","doi-asserted-by":"crossref","first-page":"17510","DOI":"10.18632\/oncotarget.15102","volume":"8","author":"D Liu","year":"2017","unstructured":"Liu D, Li S, He H et al (2017) Increased circulating full-length betatrophin levels in drug-naive metabolic syndrome. Oncotarget 8:17510\u201317517","journal-title":"Oncotarget"},{"key":"4579_CR44","doi-asserted-by":"publisher","first-page":"E2510","DOI":"10.1210\/jc.2013-4349","volume":"99","author":"T Ebert","year":"2014","unstructured":"Ebert T, Kralisch S, Hoffmann A et al (2014) Circulating angiopoietin-like protein 8 is independently associated with fasting plasma glucose and type 2 diabetes mellitus. J Clin Endocrinol Metab 99:E2510\u2013E2517","journal-title":"J Clin Endocrinol Metab"},{"key":"4579_CR45","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.1038\/srep05013","volume":"4","author":"Z Fu","year":"2014","unstructured":"Fu Z, Berhane F, Fite A, Seyoum B, Abou-Samra AB, Zhang R (2014) Elevated circulating lipasin\/betatrophin in human type 2 diabetes and obesity. Sci Rep 4:5013","journal-title":"Sci Rep"},{"key":"4579_CR46","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1055\/s-0043-102950","volume":"49","author":"C Loeffelholz von","year":"2017","unstructured":"von Loeffelholz C, Pfeiffer AF, Lock JF et al (2017) ANGPTL8 (betatrophin) is expressed in visceral adipose tissue and relates to human hepatic steatosis in two independent clinical collectives. Horm Metab Res 49:343\u2013349","journal-title":"Horm Metab Res"},{"key":"4579_CR47","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.bbrc.2012.07.038","volume":"424","author":"R Zhang","year":"2012","unstructured":"Zhang R (2012) Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun 424:786\u2013792","journal-title":"Biochem Biophys Res Commun"},{"key":"4579_CR48","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1210\/en.2016-1894","volume":"158","author":"V Gusarova","year":"2017","unstructured":"Gusarova V, Banfi S, Alexa-Braun CA et al (2017) ANGPTL8 blockade with a monoclonal antibody promotes triglyceride clearance, energy expenditure and weight loss in mice. Endocrinology 158:1252\u20131259","journal-title":"Endocrinology"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-018-4579-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4579-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4579-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T21:35:34Z","timestamp":1603920934000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-018-4579-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,1]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["4579"],"URL":"https:\/\/doi.org\/10.1007\/s00125-018-4579-1","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,1]]},"assertion":[{"value":"10 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SB and SFM report being employees and shareholders of Ionis Pharmaceuticals. The other authors declare that there is no duality of interest associated with their contribution to this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}}]}}